GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 805 filers reported holding GLAXOSMITHKLINE PLC in Q3 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,000 | +1.7% | 800 | 0.0% | 0.03% | 0.0% |
| Q2 2023 | $28,512 | +0.2% | 800 | 0.0% | 0.03% | 0.0% |
| Q1 2023 | $28,464 | +1.3% | 800 | 0.0% | 0.03% | +3.8% |
| Q4 2022 | $28,112 | +17.1% | 800 | 0.0% | 0.03% | +4.0% |
| Q3 2022 | $24,000 | -45.5% | 800 | -20.0% | 0.02% | -30.6% |
| Q2 2022 | $44,000 | 0.0% | 1,000 | 0.0% | 0.04% | -2.7% |
| Q1 2022 | $44,000 | 0.0% | 1,000 | 0.0% | 0.04% | +5.7% |
| Q4 2021 | $44,000 | +15.8% | 1,000 | 0.0% | 0.04% | +20.7% |
| Q3 2021 | $38,000 | -5.0% | 1,000 | 0.0% | 0.03% | -3.3% |
| Q2 2021 | $40,000 | +11.1% | 1,000 | 0.0% | 0.03% | 0.0% |
| Q1 2021 | $36,000 | -97.6% | 1,000 | -97.6% | 0.03% | -97.9% |
| Q4 2020 | $1,509,000 | -1.2% | 41,000 | +1.0% | 1.43% | -15.4% |
| Q3 2020 | $1,528,000 | +30.9% | 40,600 | +42.0% | 1.69% | +13.6% |
| Q2 2020 | $1,167,000 | +7.7% | 28,600 | 0.0% | 1.49% | +13.2% |
| Q1 2020 | $1,084,000 | -19.3% | 28,600 | 0.0% | 1.31% | +45.2% |
| Q4 2019 | $1,344,000 | +10.1% | 28,600 | 0.0% | 0.90% | +36.7% |
| Q3 2019 | $1,221,000 | +6.6% | 28,600 | 0.0% | 0.66% | -15.1% |
| Q2 2019 | $1,145,000 | -4.2% | 28,600 | 0.0% | 0.78% | -7.7% |
| Q1 2019 | $1,195,000 | +9.3% | 28,600 | 0.0% | 0.84% | -5.3% |
| Q4 2018 | $1,093,000 | -4.9% | 28,600 | 0.0% | 0.89% | +23.9% |
| Q3 2018 | $1,149,000 | -0.3% | 28,600 | 0.0% | 0.72% | -4.4% |
| Q2 2018 | $1,153,000 | +3.2% | 28,600 | 0.0% | 0.75% | +9.0% |
| Q1 2018 | $1,117,000 | +12.5% | 28,600 | +2.1% | 0.69% | +25.6% |
| Q4 2017 | $993,000 | -45.9% | 28,000 | -38.1% | 0.55% | -47.7% |
| Q3 2017 | $1,835,000 | -4.6% | 45,200 | +1.3% | 1.05% | -2.3% |
| Q2 2017 | $1,923,000 | +2.3% | 44,600 | 0.0% | 1.08% | -9.0% |
| Q1 2017 | $1,880,000 | +38.7% | 44,600 | +26.7% | 1.18% | +33.5% |
| Q4 2016 | $1,355,000 | +29.3% | 35,200 | +44.9% | 0.89% | +22.2% |
| Q3 2016 | $1,048,000 | -1.7% | 24,300 | -1.2% | 0.73% | -5.7% |
| Q2 2016 | $1,066,000 | +6.9% | 24,590 | 0.0% | 0.77% | +1.6% |
| Q1 2016 | $997,000 | +0.5% | 24,590 | 0.0% | 0.76% | +14.0% |
| Q4 2015 | $992,000 | -61.9% | 24,590 | -63.7% | 0.66% | -61.4% |
| Q3 2015 | $2,606,000 | -7.7% | 67,780 | 0.0% | 1.72% | +2.3% |
| Q2 2015 | $2,823,000 | -9.8% | 67,780 | 0.0% | 1.68% | -17.2% |
| Q1 2015 | $3,128,000 | +26.7% | 67,780 | +17.3% | 2.03% | +41.6% |
| Q4 2014 | $2,469,000 | +16.3% | 57,780 | +25.1% | 1.44% | +7.4% |
| Q3 2014 | $2,123,000 | -11.8% | 46,180 | +2.6% | 1.34% | -17.2% |
| Q2 2014 | $2,407,000 | +80.2% | 45,000 | +80.0% | 1.62% | +64.0% |
| Q1 2014 | $1,336,000 | – | 25,000 | – | 0.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |